New Drug Combination Kills Leukemia Cells By Shutting Down Their Energy Source
sciencedaily.com     May 16, 2008            

ScienceDaily (May 16, 2008) — Researchers at The University of Texas M. D. Anderson Cancer Center have discovered a drug combination that kills leukemia cells by shutting down their energy source and hastening cell starvation. In a preclinical study, Lauren Akers, D.O., postdoctoral fellow from... [read full story]                    


View all news articles about*:
Ambulatory Cancers Care Health Medical Research
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

Congressmen demand data from N.J. drugmakers on controversial pill

app.com     2 hrs ago          

A congressional committee is demanding that the makers of controversial cholesterol drug Vytorin, Readington-based Merck & Co. and Kenilworth-based Schering-Plough Corp., produce extensive data related to a clinical study...                    

comments

                   

Study shows how cancer gene PTEN works

upi.com     2 hrs ago   5 related          

BOSTON, Aug. 21 (UPI) -- U.S. medical scientists say they have discovered how the tumor suppressor gene PTEN works, providing new insight into its regulation. Researchers at Beth Israel Deaconess Medical Center and the Harvard...                    

comments

                   

Are wireless companies burying radiation/cancer studies?

tech.yahoo.com     2 hrs ago          

I'm the first to agree that wireless phones and other low-power radiation, like Wi-Fi, are probably not hazardous to the human body. But Walrus Magazine suggests that, like the tobacco industry before it, the truth might be...                    

comments

Onyx and Bayer begin new test of cancer drug Nexavar (at bizjournals.com)

yahoo.com     2 hrs ago   2 related          

have begun a Phase 3 test of the drug Nexavar to boost the effectiveness of two cancer treatments, the companies said Thursday. The study will evaluate the use of the Nexavar as an adjuvant treatment, which is treatment...                    

comments